A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients
Implementing Organization
Translational Health Science & Technology Institute, Haryana
Principal Investigator
Ms. N. Wadhwa
Associate Professor
|
Translational Health Science & Technology Institute, Haryana
Source
Source
Extramural R&D Projects listed in NSTMIS database 2019-20
Disclaimer:
Information available on this portal is sourced from various organizations and is provided for informational purposes only. Users are advised to verify details from the respective official sources.
Please enter your details
Please provide your name and email to continue. Your details are saved in this browser for future use.
Latest Updates
Loading…
⚠️
You are leaving this website
You are about to be redirected to an external website that is not operated by
India Science, Technology & Innovation (ISTI) Portal.